BBP
Virtus LifeSci Biotech Products
BBP
64,07
0,02 Bil. AUM
0,8% Expense Ratio
60,57 NAV
Virtus LifeSci Biotech Products Profile
About Virtus LifeSci Biotech Products
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
- Company
- Holdings
- 195
- CUSIP
- 26923G202
Virtus LifeSci Biotech Products Sectors
| Industry | Percentage |
|---|---|
| Other | 76,48% |
| Financial Servic | 6,84% |
| Real Estate | 6,02% |
| Utilities | 4,14% |
| Industrials | 3,63% |
| Communication Se | 1,94% |
| Technology | 0,88% |
| Healthcare | 0,06% |